Published in Women's Health Weekly, August 24th, 2006
"Using a variety of biochemical and cell-based approaches, we show that estrogen receptor alpha(ER alpha) is acetylated by the p300 acetylase in a ligand- and steroid receptor coactivator-dependent manner," wrote M.Y. Kim and colleagues, Cornell University.
"Using mutagenesis and mass spectrometry, we identified two conserved Lys residues in ER alpha (Lys266 and Lys268) that are the primary targets of p300-mediated acetylation. These residues are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.